LON:NIPT Premaitha Health (NIPT) Share Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free NIPT Stock Alerts GBX 9.10 +0.20 (+2.25%) (As of 11/6/2018) Add Compare Share Share Today's Range 9.10▼ 9.1050-Day Range 9.10▼ 9.1052-Week Range 3.78▼ 14.80Volume1.57 million shsAverage Volume1.35 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Premaitha Health alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Premaitha Health Stock (LON:NIPT)Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome. The IONA test is a diagnostic system that enables clinical laboratory customers to perform the test in their own facilities. The company is headquartered in Manchester, the United Kingdom.Read More NIPT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NIPT Stock News HeadlinesApril 23, 2024 | americanbankingnews.comPremaitha Health (LON:NIPT) Shares Pass Below Fifty Day Moving Average of $9.10June 14, 2023 | forbes.comWeight Loss Diets And Workouts For Women To Try In 2023April 26, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.May 10, 2023 | marketwatch.comEurope Non Invasive Prenatal Testing Market Scope, Trends, Growth Status, Share, Revenue and Forecast 2023 to 2031May 10, 2023 | marketwatch.comNon-Invasive Prenatal Testing Market Key Players, Revenue, Share, Future Trends, Growth and Forecast 2023 to 2031May 5, 2023 | marketwatch.comNon Invasive Prenatal Testing (NIPT) Market Size (2023 to 2030) New Study on Global Industry Trends and Forecast with Top Countries DataMarch 18, 2023 | finance.yahoo.comNon-Invasive Prenatal Testing (NIPT) Market Growth (2022-2030) | Industry Share, Size, Trends and Global Forecast ReportMarch 9, 2023 | fool.co.ukPremaitha HealthApril 26, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.February 23, 2023 | uk.finance.yahoo.comNon-invasive Prenatal Testing Global Market Report 2023February 19, 2023 | marketwatch.comNon-Invasive Prenatal Testing (NIPT) Market 2023: A Status of Top Regions and Companies with Growth ProspectsJuly 12, 2022 | marketwatch.comIndia Non-Invasive Prenatal Testing (NIPT) Market Size to reach 62 Million USD by 2022-2028March 6, 2022 | fool.co.ukPersimmon (LSE:PSN)November 10, 2021 | lse.co.ukPremaitha Health Share ChatSee More Headlines Receive NIPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Premaitha Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings12/29/2017Today4/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Laboratories & Research Sub-IndustryN/A Current SymbolLON:NIPT Previous SymbolLON:VIY CUSIPN/A CIKN/A Webwww.premaitha.com Phone+44-161-6676865FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesDr. Stephen Little (Age 61)Exec. Vice Chairman Mr. Barry HextallCFO, Sec. & Exec. DirectorMr. Peter Collins (Age 59)Chief Bus. Officer & Exec. Director Mr. Lyn Fafydd Rees (Age 45)CEO & Director Dr. Chia-Han Chan (Age 42)Chief Scientific Officer & Director Key CompetitorsAbzenaLON:ABZAAPR EnergyLON:APRCambian GroupLON:CMBNSinclair PharmaLON:SPHSummit TherapeuticsLON:SUMMView All Competitors NIPT Stock Analysis - Frequently Asked Questions How have NIPT shares performed in 2024? Premaitha Health's stock was trading at GBX 9.10 at the beginning of the year. Since then, NIPT shares have increased by 0.0% and is now trading at GBX 9.10. View the best growth stocks for 2024 here. How were Premaitha Health's earnings last quarter? Premaitha Health PLC (LON:NIPT) posted its quarterly earnings results on Friday, December, 29th. The company reported ($2.00) EPS for the quarter. The business earned $2.71 million during the quarter. What other stocks do shareholders of Premaitha Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Premaitha Health investors own include IQE (IQE), Avanti Communications Group (AVN), Chesapeake Utilities (CPK), Plethora Solutions (PLE), Vedanta Resources (VED), Mitie Group (MTO), Scancell (SCLP), Sirius Minerals (SXX), Advanced Micro Devices (AMD) and Aviva (AV). How do I buy shares of Premaitha Health? Shares of NIPT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:NIPT) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Premaitha Health PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
